Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents.
about
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant TherapyMechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomerDrug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.
P2860
Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@en
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@nl
type
label
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@en
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@nl
prefLabel
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@en
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@nl
P2860
P1476
Inhibition and stimulation of ...... CYP11A1 by therapeutic agents.
@en
P2093
Marlin Linger
Natalia Mast
P2860
P304
P356
10.1016/J.MCE.2012.10.013
P577
2012-10-23T00:00:00Z